Molina Healthcare, Inc.: Form 10-Q for the period ended Jun 30, 2025
Filed with the SEC on Jul 24, 2025 and accepted by EDGAR at Jul 24, 2025, 09:49 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-04-01 to 2025-06-30 | $11.43bn | us-gaap:Revenues |
| Revenue | 6 months2025-01-01 to 2025-06-30 | $22.57bn | us-gaap:Revenues |
| Cost of revenue | 3 months2025-04-01 to 2025-06-30 | $9.83bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2025-01-01 to 2025-06-30 | $19.31bn | us-gaap:CostOfGoodsAndServicesSold |
| Operating income | 3 months2025-04-01 to 2025-06-30 | $373.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2025-01-01 to 2025-06-30 | $806.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-04-01 to 2025-06-30 | $48.0m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months2025-01-01 to 2025-06-30 | $91.0m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2025-04-01 to 2025-06-30 | $70.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2025-01-01 to 2025-06-30 | $162.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-04-01 to 2025-06-30 | $255.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2025-01-01 to 2025-06-30 | $553.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-04-01 to 2025-06-30 | $4.75 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2025-01-01 to 2025-06-30 | $10.19 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-04-01 to 2025-06-30 | $4.75 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2025-01-01 to 2025-06-30 | $10.23 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-04-01 to 2025-06-30 | 53,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2025-01-01 to 2025-06-30 | 54,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2025-01-01 to 2025-06-30 | −$112.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2025-01-01 to 2025-06-30 | $64.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2025-01-01 to 2025-06-30 | $500.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-06-30 | $4.50bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-06-30 | $13.11bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-06-30 | $16.21bn | us-gaap:Assets |
| Current liabilities | At period end2025-06-30 | $7.88bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-06-30 | $11.61bn | us-gaap:Liabilities |
| Long-term debt | At period end2025-06-30 | $3.38bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2025-06-30 | $4.60bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001179929-25-000119. Last ingested by Listed: Nov 6, 2026, 17:05 ET. Listed shows no prices and gives no investment advice.